EUVIMEDEUVIMED entdecken
Open Access

Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice

Michael J Rigby, Hugo Botha, Leland R Barnard, R Ross Reichard, Rachel Larsen, Wendy Cogan, Aaron R Switzer, Vijay K Ramanan, Bryan J Neth, Ryan A Townley, Rodolfo Savica iD, David T Jones und 13 weitere

Movement Disorders · 2026

DOI: 10.1002/mds.70158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Michael J Rigby und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Lewy Body Disease, alpha-Synuclein, Cognitive Dysfunction, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Harry T. Mangurian Jr. Lewy Body Dementia program, NIDCD NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunohistochemically detected phosphorylated α‐synuclein (p‐α‐syn) in cutaneous nerves has been found in >95% of patients meeting consensus criteria for dementia with Lewy bodies (DLB); however, its performance in prodromal stages (mild cognitive impairment‐Lewy body [MCI‐LB]) and clinical practice is unknown.

Objective

We evaluated skin biopsy for p‐α‐syn in a convenience cohort of patients with suspected MCI‐LB or DLB in a tertiary care setting.

Methods

53 patients underwent commercially available skin biopsy for skin nerve p‐α‐syn as part of a clinical evaluation for suspected MCI‐LB/DLB. Consensus MCI‐LB/DLB criteria blinded to skin biopsy result were applied through retrospective chart review; those not definitively meeting criteria were considered questionable synucleinopathy (QS).

Results

Median age at skin biopsy was 70 years (range, 43–87 years) with 81% men. 36 patients (68%) had positive skin biopsies. 32/43 (74%) patients meeting clinical consensus criteria for DLB/MCI‐LB had a positive skin biopsy, with higher frequency in MCI‐LB (87%) compared with DLB (60%). 4/10 (40%) QS had positive biopsies. One patient with a positive skin biopsy had no evidence of central nervous system (CNS) α‐syn on autopsy.

Conclusions

Positive skin biopsy for p‐α‐syn occurs across the spectrum of cognitive presentations of Lewy body disease including prodromal DLB, albeit at a lower frequency in this retrospective review of atypical cases compared with typical clinical presentations. A positive skin biopsy may not reflect CNS synucleinopathy as the etiology for a patient's symptoms in some cases. Longitudinal studies of skin biopsies for p‐α‐syn in suspected MCI‐LB/DLB with autopsy confirmation are needed. © 2025 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body Diseasealpha-SynucleinCognitive DysfunctionSkinHumansMaleAgedFemaleMiddle AgedAged, 80 and overBiopsyPhosphorylationAdultRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

biomarkerdementia with Lewy bodiesmild cognitive impairment‐Lewy bodyskin biopsysynucleinopathyα‐synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Department of Neurology, University of Kansas, Kansas City, Kansas, USA.
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Rodolfo Savica, Toji Miyagawa, Erik K St Louis, Kejal Kantarci, Jonathan Graff-Radford, Stuart J McCarter

Förderung

  • Harry T. Mangurian Jr. Lewy Body Dementia program
  • NIDCD NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging

Zitieren

APA

Rigby, M. J., Botha, H., Barnard, L. R., Reichard, R. R., Larsen, R., Cogan, W., Switzer, A. R., Ramanan, V. K., Neth, B. J., Townley, R. A., Savica, R., Jones, D. T., Miyagawa, T., Fields, J. A., Vernon, C., Trottier, Z. A., Lowe, V. J., St Louis, E. K., Knopman, D. S., …, & McCarter, S. J. (2026). Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice. Movement Disorders. https://doi.org/10.1002/mds.70158

Vancouver

Rigby MJ, Botha H, Barnard LR, Reichard RR, Larsen R, Cogan W, et al. Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice. Movement Disorders. 2026. doi:10.1002/mds.70158

BibTeX
@article{Rigby2026,
  author = {Rigby, Michael J and Botha, Hugo and Barnard, Leland R and Reichard, R Ross and Larsen, Rachel and Cogan, Wendy and Switzer, Aaron R and Ramanan, Vijay K and Neth, Bryan J and Townley, Ryan A and Savica, Rodolfo and Jones, David T and Miyagawa, Toji and Fields, Julie A and Vernon, Cynthia and Trottier, Zachary A and Lowe, Val J and St Louis, Erik K and Knopman, David S and Petersen, Ronald C and Dickson, Dennis W and Kantarci, Kejal and Graff-Radford, Jonathan and Boeve, Bradley F and McCarter, Stuart J},
  title = {Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70158}
}
Kostenlos starten →